USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand Breaks.


Journal

Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042

Informations de publication

Date de publication:
03 2020
Historique:
received: 17 01 2019
revised: 15 05 2019
accepted: 29 10 2019
pubmed: 7 11 2019
medline: 20 1 2021
entrez: 6 11 2019
Statut: ppublish

Résumé

Homologous recombination (HR) is a highly conserved pathway that can facilitate the repair of DNA double-strand breaks (DSB). Several Deubiquitinases (DUB) have been implicated as key players in DNA damage repair (DDR) through HR. Here, we report USP22, a DUB that is highly overexpressed in multiple cancer types, is necessary for HR through a direct interaction with PALB2 through its C-terminal WD40 domain. This interaction stimulates USP22 catalytic activity

Identifiants

pubmed: 31685642
pii: 1541-7786.MCR-19-0053
doi: 10.1158/1541-7786.MCR-19-0053
pmc: PMC9285637
mid: NIHMS1541850
doi:

Substances chimiques

Fanconi Anemia Complementation Group N Protein 0
PALB2 protein, human 0
Ubiquitin Thiolesterase EC 3.4.19.12
Usp22 protein, human EC 3.4.19.12

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

424-435

Subventions

Organisme : Doris Duke Charitable Foundation
ID : 2016105
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA033572
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA197506
Pays : United States

Informations de copyright

©2019 American Association for Cancer Research.

Références

Mol Cancer Res. 2018 Jul;16(7):1161-1171
pubmed: 29720480
Cancer Lett. 2018 Oct 1;433:186-198
pubmed: 29981430
Nat Struct Mol Biol. 2013 Mar;20(3):317-25
pubmed: 23377543
J Struct Biol. 2016 Dec;196(3):437-447
pubmed: 27650958
Mol Cell Biol. 2001 Oct;21(20):6782-95
pubmed: 11564863
EMBO Rep. 2016 May;17(5):671-81
pubmed: 27113759
Onco Targets Ther. 2018 May 23;11:3035-3046
pubmed: 29872315
Nature. 1995 Dec 21-28;378(6559):789-92
pubmed: 8524414
Mol Cell. 2011 Mar 4;41(5):529-42
pubmed: 21362549
Mol Cell. 2011 Mar 4;41(5):515-28
pubmed: 21362548
Nature. 2015 Dec 17;528(7582):422-6
pubmed: 26649820
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9298-E9307
pubmed: 30224477
Mol Cell. 2007 Dec 14;28(5):786-97
pubmed: 18082604
Cell. 2009 Jul 23;138(2):389-403
pubmed: 19615732
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12811-6
pubmed: 25136098
J Cell Physiol. 2017 Dec;232(12):3664-3676
pubmed: 28160502
Genetics. 2006 Aug;173(4):1951-68
pubmed: 16783014
Front Microbiol. 2014 Apr 17;5:172
pubmed: 24860555
Cell Cycle. 2011 Oct 15;10(20):3495-504
pubmed: 22031019
Mol Cell. 2008 Jan 18;29(1):102-11
pubmed: 18206973
Nat Struct Mol Biol. 2010 Oct;17(10):1255-9
pubmed: 20871616
Annu Rev Biochem. 2009;78:363-97
pubmed: 19489724
Int J Mol Sci. 2017 Aug 31;18(9):
pubmed: 28858227
Curr Biol. 2009 Mar 24;19(6):524-9
pubmed: 19268590
Proteins. 2007 Jun 1;67(4):1078-86
pubmed: 17373710
Mol Cell. 2012 May 25;46(4):484-94
pubmed: 22542455
Front Pharmacol. 2017 May 17;8:274
pubmed: 28567015
Cell Biochem Biophys. 2013 Sep;67(1):111-26
pubmed: 23797609
Elife. 2017 Feb 27;6:
pubmed: 28240985
EMBO Rep. 2009 Sep;10(9):990-6
pubmed: 19609323
Mol Cell Biol. 2011 Jun;31(12):2462-9
pubmed: 21482670
Nat Commun. 2018 Mar 8;9(1):1006
pubmed: 29520062
Epigenetics. 2010 Aug 16;5(6):460-8
pubmed: 20523115
Cell Signal. 2012 Feb;24(2):410-421
pubmed: 22033037
Nature. 2001 May 17;411(6835):366-74
pubmed: 11357144
Mol Cell Biol. 2011 Sep;31(18):3734-44
pubmed: 21746879
Mol Cell. 2008 Jan 18;29(1):92-101
pubmed: 18206972
J Biol Chem. 2009 Feb 20;284(8):5343-51
pubmed: 19075014
Cell. 2010 May 14;141(4):606-17
pubmed: 20434206
Nat Struct Mol Biol. 2010 Oct;17(10):1247-54
pubmed: 20871615
Mol Cell. 2016 Mar 3;61(5):774-787
pubmed: 26942680
Science. 1994 Sep 30;265(5181):2088-90
pubmed: 8091231
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2298-302
pubmed: 7892263
Nat Struct Mol Biol. 2014 Mar;21(3):236-43
pubmed: 24531659
Cell Rep. 2016 May 17;15(7):1554-1565
pubmed: 27160905
J Cell Biol. 1999 Sep 6;146(5):905-16
pubmed: 10477747
PLoS One. 2011;6(9):e24657
pubmed: 21949741
Oncogene. 2014 Oct 2;33(40):4803-12
pubmed: 24141787
Mol Cell Biol. 2008 Feb;28(3):897-906
pubmed: 18039855

Auteurs

Isaac K Nardi (IK)

Division of Thoracic Surgery, Baum Family Thoracic Oncology Laboratory, City of Hope National Medical Center, Duarte, California. inardi@coh.org.
Beckman Research Institute, City of Hope National Medical Center, Duarte, California.

Jeremy M Stark (JM)

Department of Cancer Genetics and Epigenetics, City of Hope National Medical Center, Duarte, California.

Adrien Larsen (A)

Department of Computational Therapeutics, City of Hope National Medical Center, Duarte, California.

Ravi Salgia (R)

Department of Medical Oncology, City of Hope National Medical Center, Duarte, California.

Dan J Raz (DJ)

Division of Thoracic Surgery, Baum Family Thoracic Oncology Laboratory, City of Hope National Medical Center, Duarte, California.
Beckman Research Institute, City of Hope National Medical Center, Duarte, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH